Carl Zeiss Meditec (ETR:AFX) Stock Price Down 3% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX)’s stock price fell 3% during mid-day trading on Friday . The company traded as low as €27.04 and last traded at €27.34. 268,173 shares traded hands during mid-day trading, an increase of 184% from the average session volume of 94,405 shares. The stock had previously closed at €28.20.

Carl Zeiss Meditec Stock Down 3.0%

The company has a debt-to-equity ratio of 29.43, a current ratio of 2.43 and a quick ratio of 2.47. The stock has a market capitalization of $2.55 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 2.83 and a beta of 1.33. The firm’s fifty day moving average is €27.01 and its 200-day moving average is €27.78.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.